WNV Treatment Trial Begins

GenoMed, a medical genomics company, is seeking horses to participate in a free trial to test a medical protocol for treating West Nile virus (WNV). David W. Moskowitz, MD, MA, FACP, chairman, CEO, and chief medical officer for GenoMed, said the treatment protocol has already been successful in limited human trials.

The treatment uses either angiotensin converting enzyme (ACE)

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners